| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $0.36 | $8.9k | | 06/28/2023 |
| 12/21/2022 | Tracon Pharmaceuticals, Inc. | TCON | Sale | Common Stock | 120 | $1.26 | $150.6 | | 12/21/2022 |
| 06/16/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $1.08 | $27k | | 06/16/2022 |
| 06/14/2022 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15.8k | $1.30 | $20.5k | | 06/14/2022 |
| 07/26/2021 | Tracon Pharmaceuticals, Inc. | TCON | Purchase | Common Stock | 6.5k | $3.82 | $25k | | 07/26/2021 |
| 06/10/2021 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 10.5k | $6.55 | $68.8k | | 06/10/2021 |
| 05/25/2021 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $5.14 | $128.5k | | 05/25/2021 |
| 06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 15k | $2.94 | $44.1k | | 06/11/2020 |
| 06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 15k | $2.94 | $44.1k | | 06/11/2020 |
| 06/10/2020 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 4.5k | $2.07 | $9.3k | | 06/10/2020 |
| 09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 30k | $5.76 | $172.8k | | 09/12/2019 |
| 09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 30k | $5.76 | $172.8k | | 09/12/2019 |
| 06/27/2019 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $0.29 | $5.8k | | 06/27/2019 |
| 06/13/2019 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $0.64 | $9.5k | | 06/13/2019 |
| 06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 16.1k | $0.00 | $0 | | 06/07/2019 |
| 06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 10k | $0.00 | $0 | By family trust | 06/07/2019 |
| 06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Warrants | 281 | $6.13 | $1.7k | By family trust. | 06/07/2019 |
| 06/21/2018 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $4.99 | $99.8k | | 06/21/2018 |
| 06/13/2018 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $2.70 | $40.5k | | 06/13/2018 |
| 06/15/2017 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $2.15 | $32.2k | | 06/15/2017 |
| 06/02/2017 | Tracon Pharmaceuticals, Inc. | TCON | Sale | Common Stock | 2.5k | $2.69 | $6.7k | | 06/02/2017 |
| 02/06/2017 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 30k | $5.09 | $152.7k | | 02/06/2017 |
| 06/01/2016 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Common Stock | 7.5k | $0.00 | $0 | | 06/01/2016 |
| 07/23/2015 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option ( Right to Buy) | 15k | $13.02 | $195.3k | | 07/23/2015 |
| 07/23/2015 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option ( Right to Buy) | 12.5k | $13.02 | $163.4k | | 07/23/2015 |
| 11/02/2011 | CADENCE PHARMACEUTICALS INC | CADX | Exercise | Restricted Stock Units | 10k | $0.00 | $0 | | 11/02/2011 |
| 03/16/2011 | CADENCE PHARMACEUTICALS INC | CADX | Grant | stock option (right to buy) | 125k | $8.55 | $1.1M | | 03/16/2011 |